FDA

Flow Medical has successfully secured $5 million in an oversubscribed seed financing round, as stated by the thrombolysis catheter innovators today. The round builds on a previously announced $2 million contribution from friends and family, along with new capital from […]

Merit Medical Systems (Nasdaq:MMSI) has announced that Joseph C. Wright, its current President, will step down from his position, effective January 3, 2025. The organization, based in South Jordan, Utah, specializes in producing disposable medical devices, and attributed Wright’s decision

Teleflex, trading under TFX, may finalize a deal to purchase Biotronik’s vascular intervention segment by the end of this month. Reports from December 4, as published by Bloomberg, revealed inside information indicating that Teleflex is contemplating an offer ranging from

Abbott (NYSE: ABT) today announced the landmark completion of the initial human cases of leadless left bundle branch area pacing (LBBAP). The pioneering procedures, conducted using Abbott’s investigational Aveir conduction system pacing (CSP) leadless pacemaker, are part of an exploratory

FDA Raises Alert Following Boston Scientific’s Caution on Early Pacemaker Replacement In a recent announcement, Boston Scientific (NYSE: BSX) revealed the potential necessity for earlier-than-anticipated replacements of specific pacemaker models. This alert prompted the FDA to issue a notice to

Withings Health Solutions proudly announced FDA clearance for their innovative cellular blood pressure monitor, BPM Pro 2. This breakthrough device aims to transform clinical workflows by offering seamless measurement of blood pressure and pulse rate for adults with varying arm

Adagio Medical (Nasdaq: ADGM) has revealed its new leadership decision with the appointment of Todd Usen as CEO and board director. The decision comes after the recent exit of Olav Bergheim, who was the founder, CEO, and board chair. Bergheim’s

HeartBeam (Nasdaq:BEAT) has announced the approval of its comprehensive arrhythmia assessment system by the FDA, under 510(k) clearance. The innovative device, developed by the Santa Clara, California-based company, is the first of its kind to earn such approval. This advanced

FastWave Medical revealed today it has successfully completed a funding round, surpassing expectations to secure $19 million in proceeds. Based in Minneapolis, FastWave focuses on the development of intravascular lithotripsy (IVL) technology. This latest financing elevates their total funding to

Boston Scientific (NYSE: BSX) has named Kathleen Van Vlierberghe as Vice President for Peripheral Interventions in the Europe, Middle East, and Africa (EMEA) region. Her new role commenced on December 1, 2024. Van Vlierberghe joins this position with over 25